{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:10:38Z","timestamp":1790795438252,"version":"4.1.0"},"reference-count":119,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,16]],"date-time":"2019-02-16T00:00:00Z","timestamp":1550275200000},"content-version":"am","delay-in-days":380,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009139","name":"German Center of Infection Research","doi-asserted-by":"publisher","award":["DZIF-TTU01.702"],"award-info":[{"award-number":["DZIF-TTU01.702"]}],"id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases of the National Institutes of Health","doi-asserted-by":"publisher","award":["K08 AI119448"],"award-info":[{"award-number":["K08 AI119448"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases of the National Institutes of Health","doi-asserted-by":"publisher","award":["R21 AI082954"],"award-info":[{"award-number":["R21 AI082954"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome CAMS","doi-asserted-by":"publisher","award":["1013362.01"],"award-info":[{"award-number":["1013362.01"]}],"id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000774","name":"Defense Threat Reduction Agency","doi-asserted-by":"publisher","award":["HDTRA1-14-1-0016"],"award-info":[{"award-number":["HDTRA1-14-1-0016"]}],"id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Virology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.coviro.2018.01.010","type":"journal-article","created":{"date-parts":[[2018,2,16]],"date-time":"2018-02-16T09:18:22Z","timestamp":1518772702000},"page":"152-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Immune barriers of Ebola virus infection"],"prefix":"10.1016","volume":"28","author":[{"given":"Anita K","family":"McElroy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"M\u00fchlberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9sar","family":"Mu\u00f1oz-Fontela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coviro.2018.01.010_bib0600","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1126\/science.1057269","article-title":"Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity","volume":"291","author":"Volchkov","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.coviro.2018.01.010_bib0605","first-page":"271","article-title":"Ebola haemorrhagic fever in Zaire, 1976","volume":"56","year":"1978","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.coviro.2018.01.010_bib0610","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(77)92000-1","article-title":"Isolation and partial characterisation of a new virus causing acute haemorrhagic fever in Zaire","volume":"1","author":"Johnson","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.coviro.2018.01.010_bib0615","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/path.1711250303","article-title":"The pathology of experimental Ebola virus infection in monkeys","volume":"125","author":"Baskerville","year":"1978","journal-title":"J Pathol"},{"key":"10.1016\/j.coviro.2018.01.010_bib0620","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/0035-9203(78)90058-5","article-title":"Ebola haemorrhagic fever: experimental infection of monkeys","volume":"72","author":"Bowen","year":"1978","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.coviro.2018.01.010_bib0625","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0140-6736(92)91770-9","article-title":"Filovirus clearance in non-human primates","volume":"340","author":"Fisher-Hoch","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.coviro.2018.01.010_bib0630","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/infdis\/152.5.887","article-title":"Pathophysiology of shock and hemorrhage in a fulminating viral infection (Ebola)","volume":"152","author":"Fisher-Hoch","year":"1985","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2018.01.010_bib0635","first-page":"227","article-title":"Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus","volume":"76","author":"Johnson","year":"1995","journal-title":"Int J Exp Pathol"},{"issue":"Suppl. 1","key":"10.1016\/j.coviro.2018.01.010_bib0640","doi-asserted-by":"crossref","first-page":"S199","DOI":"10.1086\/514293","article-title":"An analysis of features of pathogenesis in two animal models of Ebola virus infection","volume":"179","author":"Ryabchikova","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2018.01.010_bib0645","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/S0002-9440(10)63591-2","article-title":"Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection","volume":"163","author":"Geisbert","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.coviro.2018.01.010_bib0650","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/7422","article-title":"Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients","volume":"5","author":"Baize","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.coviro.2018.01.010_bib0655","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nrmicro3524","article-title":"Filovirus pathogenesis and immune evasion: insights from Ebola virus and Marburg virus","volume":"13","author":"Messaoudi","year":"2015","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.coviro.2018.01.010_bib0660","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.biocel.2005.02.018","article-title":"Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever","volume":"37","author":"Bray","year":"2005","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.coviro.2018.01.010_bib0665","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/infdis\/jiu088","article-title":"Ebola hemorrhagic fever: novel biomarker correlates of clinical outcome","volume":"210","author":"McElroy","year":"2014","journal-title":"J Infect Dis"},{"issue":"Suppl. 2","key":"10.1016\/j.coviro.2018.01.010_bib0670","doi-asserted-by":"crossref","first-page":"S357","DOI":"10.1086\/520611","article-title":"Cytokine and chemokine expression in humans infected with Sudan Ebola virus","volume":"196","author":"Hutchinson","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2018.01.010_bib0675","first-page":"1","article-title":"Mechanisms of filovirus entry","volume":"26","author":"Davey","year":"2017","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.coviro.2018.01.010_bib0680","doi-asserted-by":"crossref","first-page":"e1001110","DOI":"10.1371\/journal.ppat.1001110","article-title":"Cellular entry of ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes","volume":"6","author":"Saeed","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2018.01.010_bib0685","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature10348","article-title":"Ebola virus entry requires the cholesterol transporter Niemann-Pick C1","volume":"477","author":"Carette","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2018.01.010_bib0690","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nature10380","article-title":"Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection","volume":"477","author":"C\u00f4t\u00e9","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2018.01.010_bib0695","doi-asserted-by":"crossref","first-page":"e00565","DOI":"10.1128\/mBio.00565-15","article-title":"Niemann-pick c1 is essential for ebolavirus replication and pathogenesis in vivo","volume":"6","author":"Herbert","year":"2015","journal-title":"MBio"},{"key":"10.1016\/j.coviro.2018.01.010_sbref0700","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.11785","article-title":"Filovirus receptor NPC1 contributes to species-specific patterns of ebolavirus susceptibility in bats","volume":"4","author":"Ng","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.coviro.2018.01.010_bib0705","doi-asserted-by":"crossref","first-page":"e00007","DOI":"10.1128\/mSphere.00007-16","article-title":"A single residue in Ebola virus receptor NPC1 influences cellular host range in reptiles","volume":"1","author":"Ndungo","year":"2016","journal-title":"mSphere"},{"key":"10.1016\/j.coviro.2018.01.010_bib0710","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.3390\/v3081501","article-title":"Intracellular events and cell fate in filovirus infection","volume":"3","author":"Olejnik","year":"2011","journal-title":"Viruses"},{"key":"10.1016\/j.coviro.2018.01.010_bib0715","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2018.01.010_bib0720","first-page":"87","article-title":"Measurement of antibodies to Ebola virus in human sera from N. W.-Zaire","volume":"59","author":"Van der Groen","year":"1979","journal-title":"Ann Soc Belg Med Trop"},{"key":"10.1016\/j.coviro.2018.01.010_bib0725","first-page":"238","article-title":"Preliminary note on the presence of antibodies to Ebola virus in the human population in the eastern part of the Central African Republic","volume":"73","author":"Saluzzo","year":"1980","journal-title":"Bull Soc Pathol Exot Filiales"},{"key":"10.1016\/j.coviro.2018.01.010_bib0730","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/infdis\/142.3.372","article-title":"Ebola hemorrhagic fever: Tandala, Zaire, 1977\u20131978","volume":"142","author":"Heymann","year":"1980","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2018.01.010_bib0735","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.4269\/ajtmh.1983.32.1465","article-title":"Ebola virus infection in man: a serological and epidemiological survey in the Cameroons","volume":"32","author":"Bouree","year":"1983","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.coviro.2018.01.010_bib0740","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/01913129809032253","article-title":"Marburg hemorrhagic fever: report of a case studied by immunohistochemistry and electron microscopy","volume":"22","author":"Geisbert","year":"1998","journal-title":"Ultrastruct Pathol"},{"issue":"Suppl. 1","key":"10.1016\/j.coviro.2018.01.010_bib0745","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1086\/514300","article-title":"Histopathological and immunohistochemical studies of lesions associated with Ebola virus in a naturally infected chimpanzee","volume":"179","author":"Wyers","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2018.01.010_bib0750","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0021-9975(92)90043-T","article-title":"Association of Ebola-related Reston virus particles and antigen with tissue lesions of monkeys imported to the United States","volume":"106","author":"Geisbert","year":"1992","journal-title":"J Comp Pathol"},{"key":"10.1016\/j.coviro.2018.01.010_bib0755","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1172\/JCI60659","article-title":"Cross-presenting CD103+ dendritic cells are protected from influenza virus infection","volume":"122","author":"Helft","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coviro.2018.01.010_bib0760","doi-asserted-by":"crossref","first-page":"625","DOI":"10.5858\/2001-125-0625-EVGDDC","article-title":"Ebola virus glycoprotein demonstrates differential cellular localization in infected cell types of nonhuman primates and guinea pigs","volume":"125","author":"Steele","year":"2001","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.coviro.2018.01.010_sbref0765","doi-asserted-by":"crossref","first-page":"43776","DOI":"10.1038\/srep43776","article-title":"Ebola virus infection kinetics in chimeric mice reveal a key role of T cells as barriers for virus dissemination","volume":"7","author":"L\u00fcdtke","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.coviro.2018.01.010_bib0770","doi-asserted-by":"crossref","first-page":"7732","DOI":"10.4049\/jimmunol.0902707","article-title":"Langerin+ CD8alpha+ dendritic cells are critical for cross-priming and IL-12 production in response to systemic antigens","volume":"183","author":"Farrand","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.coviro.2018.01.010_bib0775","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/ni.1724","article-title":"Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells","volume":"10","author":"Bedoui","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coviro.2018.01.010_bib0780","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nature20567","article-title":"Receptor usage dictates HIV-1 restriction by human TRIM5\u03b1 in dendritic cell subsets","volume":"540","author":"Ribeiro","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2018.01.010_bib0785","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aai8071","article-title":"Constitutive resistance to viral infection in human CD141(+) dendritic cells","volume":"2","author":"Silvin","year":"2017","journal-title":"Sci Immunol"},{"key":"10.1016\/j.coviro.2018.01.010_bib0790","doi-asserted-by":"crossref","first-page":"11025","DOI":"10.1128\/JVI.75.22.11025-11033.2001","article-title":"Infection and activation of monocytes by Marburg and Ebola viruses","volume":"75","author":"Str\u00f6her","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2018.01.010_bib0795","doi-asserted-by":"crossref","first-page":"e1359","DOI":"10.1371\/journal.pntd.0001359","article-title":"Ebola virion attachment and entry into human macrophages profoundly effects early cellular gene expression","volume":"5","author":"Wahl-Jensen","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.coviro.2018.01.010_sbref0800","doi-asserted-by":"crossref","first-page":"e00179","DOI":"10.1128\/JVI.00179-17","article-title":"Ebolaviruses associated with differential pathogenicity induce distinct host responses in human macrophages","volume":"91","author":"Olejnik","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2018.01.010_bib0805","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1006\/viro.2001.0836","article-title":"Monocyte-derived human macrophages and peripheral blood mononuclear cells infected with ebola virus secrete MIP-1alpha and TNF-alpha and inhibit poly-IC-induced IFN-alpha in vitro","volume":"284","author":"Gupta","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2018.01.010_bib0810","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0165-2478(01)00327-3","article-title":"Proinflammatory response during Ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamily","volume":"80","author":"Hensley","year":"2002","journal-title":"Immunol Lett"},{"key":"10.1016\/j.coviro.2018.01.010_bib0815","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1128\/JVI.01462-09","article-title":"Interaction between Ebola virus glycoprotein and host toll-like receptor 4 leads to induction of proinflammatory cytokines and SOCS1","volume":"84","author":"Okumura","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2018.01.010_bib0820","doi-asserted-by":"crossref","first-page":"e1004509","DOI":"10.1371\/journal.ppat.1004509","article-title":"Shed GP of Ebola virus triggers immune activation and increased vascular permeability","volume":"10","author":"Escudero-P\u00e9rez","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2018.01.010_bib0825","doi-asserted-by":"crossref","first-page":"10399","DOI":"10.1128\/JVI.01736-15","article-title":"Suppressor of cytokine signaling 3 is an inducible host factor that regulates virus egress during Ebola virus infection","volume":"89","author":"Okumura","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2018.01.010_bib0830","doi-asserted-by":"crossref","first-page":"6187","DOI":"10.1128\/JVI.02903-15","article-title":"Hepatitis B virus surface antigen activates myeloid dendritic cells via a soluble CD14-dependent mechanism","volume":"90","author":"van Montfoort","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2018.01.010_bib0835","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa3863","article-title":"Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity","volume":"7","author":"Modhiran","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coviro.2018.01.010_bib0840","doi-asserted-by":"crossref","first-page":"e0124082","DOI":"10.1371\/journal.pone.0124082","article-title":"Respiratory syncytial virus fusion protein promotes TLR-4-dependent neutrophil extracellular trap formation by human neutrophils","volume":"10","author":"Funchal","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.coviro.2018.01.010_sbref0845","article-title":"Marburg virus survivor immune responses are Th1 skewed with limited neutralizing antibody responses","volume":"58","author":"Stonier","year":"2017","journal-title":"J Exp Med"},{"key":"10.1016\/j.coviro.2018.01.010_sbref0850","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1073\/pnas.1502619112","article-title":"Human Ebola virus infection results in substantial immune activation","volume":"112","author":"McElroy","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coviro.2018.01.010_bib0855","doi-asserted-by":"crossref","first-page":"4524","DOI":"10.4049\/jimmunol.168.9.4524","article-title":"Toll-like receptor 4 is required for optimal development of Th2 immune responses: role of dendritic cells","volume":"168","author":"Dabbagh","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.coviro.2018.01.010_bib0860","doi-asserted-by":"crossref","first-page":"e1006397","DOI":"10.1371\/journal.ppat.1006397","article-title":"Ebola virus glycoprotein directly triggers T lymphocyte death despite of the lack of infection","volume":"13","author":"Iampietro","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2018.01.010_bib0865","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(10)60667-8","article-title":"Ebola haemorrhagic fever","volume":"377","author":"Feldmann","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.coviro.2018.01.010_bib0870","doi-asserted-by":"crossref","first-page":"e00845","DOI":"10.1128\/mBio.00845-17","article-title":"Ebola virus binding to Tim-1 on T lymphocytes induces a cytokine storm","volume":"8","author":"Younan","year":"2017","journal-title":"MBio"},{"key":"10.1016\/j.coviro.2018.01.010_bib0875","doi-asserted-by":"crossref","DOI":"10.1126\/science.aad7993","article-title":"Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation","volume":"352","author":"Rialdi","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.coviro.2018.01.010_bib0880","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00179-17","article-title":"Ebolaviruses associated with differential pathogenicity induce distinct host responses in human macrophages","volume":"91","author":"Olejnik","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2018.01.010_bib0885","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00226-17","article-title":"The toll-like receptor 4 antagonist eritoran protects mice from lethal filovirus challenge","volume":"8","author":"Younan","year":"2017","journal-title":"MBio"},{"key":"10.1016\/j.coviro.2018.01.010_bib0890","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1084\/jem.20090247","article-title":"Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant","volume":"206","author":"Longhi","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.coviro.2018.01.010_bib0895","doi-asserted-by":"crossref","first-page":"e1002345","DOI":"10.1371\/journal.ppat.1002345","article-title":"Unique type I interferon responses determine the functional fate of migratory lung dendritic cells during influenza virus infection","volume":"7","author":"Moltedo","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2018.01.010_bib0900","doi-asserted-by":"crossref","first-page":"e1002407","DOI":"10.1371\/journal.ppat.1002407","article-title":"A temporal role of type I interferon signaling in CD8+ T cell maturation during acute West Nile virus infection","volume":"7","author":"Pinto","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2018.01.010_sbref0905","doi-asserted-by":"crossref","first-page":"e1005263","DOI":"10.1371\/journal.ppat.1005263","article-title":"Interferon-\u03b3 inhibits Ebola virus infection","volume":"11","author":"Rhein","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2018.01.010_bib0910","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/infdis\/jix134","article-title":"Interferon-\u03b2 and interferon-\u03b3 are weak inhibitors of Ebola virus in cell-based assays","volume":"215","author":"Dyall","year":"2017","journal-title":"J Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.coviro.2018.01.010_bib0915","doi-asserted-by":"crossref","first-page":"S224","DOI":"10.1086\/514310","article-title":"Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections","volume":"179","author":"Jahrling","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2018.01.010_bib0920","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/infdis\/jis921","article-title":"Interferon-\u03b2 therapy prolongs survival in rhesus macaque models of Ebola and Marburg hemorrhagic fever","volume":"208","author":"Smith","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2018.01.010_bib0925","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006605","article-title":"mAbs and Ad-vectored IFN-\u03b1 therapy rescue Ebola-infected nonhuman primates when administered after the detection of viremia and symptoms","volume":"5","author":"Qiu","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coviro.2018.01.010_bib0930","first-page":"499","article-title":"Filovirus strategies to escape antiviral responses","volume":"4","author":"Olejnik","year":"2017","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.coviro.2018.01.010_bib0935","doi-asserted-by":"crossref","first-page":"12500","DOI":"10.1128\/JVI.02163-14","article-title":"Molecular basis for Ebola virus VP35 suppression of human dendritic cell maturation","volume":"88","author":"Yen","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2018.01.010_sbref0940","doi-asserted-by":"crossref","first-page":"7567","DOI":"10.1128\/JVI.00924-15","article-title":"Different temporal effects of Ebola virus VP35 and VP24 proteins on global gene expression in human dendritic cells","volume":"89","author":"Ilinykh","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2018.01.010_bib0945","doi-asserted-by":"crossref","first-page":"e1006031","DOI":"10.1371\/journal.ppat.1006031","article-title":"The Ebola interferon inhibiting domains attenuate and dysregulate cell-mediated immune responses","volume":"12","author":"Lubaki","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2018.01.010_bib0950","doi-asserted-by":"crossref","first-page":"6430","DOI":"10.1128\/JVI.00044-06","article-title":"Reverse genetic generation of recombinant Zaire Ebola viruses containing disrupted IRF-3 inhibitory domains results in attenuated virus growth in vitro and higher levels of IRF-3 activation without inhibiting viral transcription or replication","volume":"80","author":"Hartman","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2018.01.010_bib0955","doi-asserted-by":"crossref","first-page":"5348","DOI":"10.1128\/JVI.00215-08","article-title":"Whole-genome expression profiling reveals that inhibition of host innate immune response pathways by Ebola virus can be reversed by a single amino acid change in the VP35 protein","volume":"82","author":"Hartman","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2018.01.010_bib0960","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1128\/JVI.02344-07","article-title":"Inhibition of IRF-3 activation by VP35 is critical for the high level of virulence of ebola virus","volume":"82","author":"Hartman","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2018.01.010_bib0965","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1006\/viro.2000.0572","article-title":"Molecular characterization of guinea pig-adapted variants of Ebola virus","volume":"277","author":"Volchkov","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2018.01.010_bib0970","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1371\/journal.ppat.0020073","article-title":"Molecular determinants of Ebola virus virulence in mice","volume":"2","author":"Ebihara","year":"2006","journal-title":"PLoS Pathog"},{"issue":"Suppl. 3","key":"10.1016\/j.coviro.2018.01.010_bib0975","doi-asserted-by":"crossref","first-page":"S892","DOI":"10.1093\/infdis\/jir311","article-title":"Knockdown of Ebola virus VP24 impairs viral nucleocapsid assembly and prevents virus replication","volume":"204","author":"Mateo","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2018.01.010_bib0980","doi-asserted-by":"crossref","first-page":"13469","DOI":"10.1128\/JVI.01097-07","article-title":"Ebola virus VP24 proteins inhibit the interaction of NPI-1 subfamily karyopherin alpha proteins with activated STAT1","volume":"81","author":"Reid","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2018.01.010_sbref0985","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1056\/NEJMoa1511410","article-title":"Ebola RNA persistence in semen of Ebola virus disease survivors\u2014final report","volume":"377","author":"Deen","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2018.01.010_bib0990","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1186\/s12864-016-3060-0","article-title":"In vivo Ebola virus infection leads to a strong innate response in circulating immune cells","volume":"17","author":"Caballero","year":"2016","journal-title":"BMC Genomics"},{"key":"10.1016\/j.coviro.2018.01.010_bib0995","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13059-016-1137-3","article-title":"Transcriptomic signatures differentiate survival from fatal outcomes in humans infected with Ebola virus","volume":"18","author":"Liu","year":"2017","journal-title":"Genome Biol"},{"key":"10.1016\/j.coviro.2018.01.010_bib1000","doi-asserted-by":"crossref","first-page":"10370","DOI":"10.1128\/JVI.78.19.10370-10377.2004","article-title":"Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels","volume":"78","author":"Sanchez","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2018.01.010_bib1005","first-page":"4","article-title":"Human fatal Zaire Ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis","author":"Wauquier","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.coviro.2018.01.010_bib1010","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1128\/JVI.78.8.4330-4341.2004","article-title":"Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome","volume":"78","author":"Towner","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2018.01.010_bib1015","doi-asserted-by":"crossref","first-page":"4058","DOI":"10.4049\/jimmunol.180.6.4058","article-title":"Functional CD8+ T cell responses in lethal Ebola virus infection","volume":"180","author":"Bradfute","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.coviro.2018.01.010_bib1020","doi-asserted-by":"crossref","first-page":"327","DOI":"10.4049\/jimmunol.0901231","article-title":"Mechanisms and consequences of ebolavirus-induced lymphocyte apoptosis","volume":"184","author":"Bradfute","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.coviro.2018.01.010_bib1025","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1128\/JVI.78.2.958-967.2004","article-title":"Persistent infection with ebola virus under conditions of partial immunity","volume":"78","author":"Gupta","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2018.01.010_sbref1030","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature17949","article-title":"Unique human immune signature of Ebola virus disease in Guinea","volume":"533","author":"Ruibal","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2018.01.010_bib1035","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1073\/pnas.1502619112","article-title":"Human Ebola virus infection results in substantial immune activation","volume":"112","author":"McElroy","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl. 1","key":"10.1016\/j.coviro.2018.01.010_bib1040","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1086\/514318","article-title":"Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epid\u00e9mies \u00e0 Kikwit","volume":"179","author":"Rowe","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2018.01.010_bib1045","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.virusres.2015.12.019","article-title":"Specific neutralizing response in plasma from convalescent patients of Ebola Virus Disease against the West Africa Makona variant of Ebola virus","volume":"213","author":"Luczkowiak","year":"2016","journal-title":"Virus Res"},{"key":"10.1016\/j.coviro.2018.01.010_bib1050","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.coviro.2016.01.006","article-title":"Antibody therapeutics for Ebola virus disease","volume":"17","author":"Zeitlin","year":"2016","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.coviro.2018.01.010_bib1055","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1056\/NEJMc1300266","article-title":"Persistent immune responses after ebola virus infection","volume":"369","author":"Sobarzo","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2018.01.010_bib1060","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/infdis\/jit162","article-title":"Profile and persistence of the virus-specific neutralizing humoral immune response in human survivors of Sudan ebolavirus (Gulu)","volume":"208","author":"Sobarzo","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2018.01.010_bib1065","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3390\/v8050133","article-title":"Correspondence of neutralizing humoral immunity and CD4 T cell responses in long recovered sudan virus survivors","volume":"8","author":"Sobarzo","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.coviro.2018.01.010_bib1070","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S1473-3099(15)70152-0","article-title":"Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study","volume":"15","author":"Clark","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.coviro.2018.01.010_bib1075","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S1473-3099(16)30516-3","article-title":"Multidisciplinary assessment of post-Ebola sequelae in Guinea (Postebogui): an observational cohort study","volume":"17","author":"Etard","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.coviro.2018.01.010_bib1080","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1473-3099(15)00489-2","article-title":"Early clinical sequelae of Ebola virus disease in Sierra Leone: a cross-sectional study","volume":"16","author":"Mattia","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.coviro.2018.01.010_bib1085","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3201\/eid2202.151416","article-title":"Uveitis and systemic inflammatory markers in convalescent phase of Ebola virus disease","volume":"22","author":"Chancellor","year":"2016","journal-title":"Emerging Infect Dis"},{"key":"10.1016\/j.coviro.2018.01.010_sbref1090","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0140-6736(16)30386-5","article-title":"Late Ebola virus relapse causing meningoencephalitis: a case report","volume":"388","author":"Jacobs","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.coviro.2018.01.010_sbref1095","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1056\/NEJMoa1500306","article-title":"Persistence of Ebola virus in ocular fluid during convalescence","volume":"372","author":"Varkey","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2018.01.010_bib1100","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1084\/jem.190.9.1197","article-title":"Immune privilege: keeping an eye on natural killer T cells","volume":"190","author":"Hong","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.coviro.2018.01.010_sbref1105","doi-asserted-by":"crossref","first-page":"17113","DOI":"10.1038\/nmicrobiol.2017.113","article-title":"Identification and pathological characterization of persistent asymptomatic Ebola virus infection in rhesus monkeys","volume":"2","author":"Zeng","year":"2017","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.coviro.2018.01.010_bib1110","doi-asserted-by":"crossref","first-page":"ftw021","DOI":"10.1093\/femspd\/ftw021","article-title":"Cell-targeting antibodies in immunity to Ebola","volume":"74","author":"Schmaljohn","year":"2016","journal-title":"Pathog Dis"},{"key":"10.1016\/j.coviro.2018.01.010_bib1115","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s11262-017-1455-x","article-title":"Ebola and Marburg virus vaccines","volume":"53","author":"Reynolds","year":"2017","journal-title":"Virus Genes"},{"key":"10.1016\/j.coviro.2018.01.010_bib1120","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/nm.2447","article-title":"CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates","volume":"17","author":"Sullivan","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.coviro.2018.01.010_bib1125","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1073\/pnas.1209591110","article-title":"Antibodies are necessary for rVSV\/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates","volume":"110","author":"Marzi","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2018.01.010_bib1130","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.vaccine.2010.10.037","article-title":"A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults","volume":"29","author":"Ledgerwood","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2018.01.010_bib1135","first-page":"776","article-title":"Chimpanzee adenovirus vector Ebola vaccine\u2014preliminary report","volume":"373","author":"Ledgerwood","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2018.01.010_bib1140","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0140-6736(16)32617-4","article-title":"Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"389","author":"Zhu","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.coviro.2018.01.010_bib1145","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaj1701","article-title":"A dose-dependent plasma signature of the safety and immunogenicity of the rVSV-Ebola vaccine in Europe and Africa","volume":"9","author":"Huttner","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coviro.2018.01.010_bib1150","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1473-3099(15)00362-X","volume":"16","author":"Tapia","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.coviro.2018.01.010_bib1155","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1473-3099(15)00486-7","article-title":"Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1\/2a study","volume":"16","author":"De Santis","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.coviro.2018.01.010_bib1160","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMoa1502924","article-title":"Phase 1 trials of rVSV Ebola vaccine in Africa and Europe\u2014preliminary report","volume":"374","author":"Agnandji","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2018.01.010_bib1165","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1056\/NEJMoa1411627","article-title":"A monovalent chimpanzee adenovirus Ebola vaccine boosted with MVA","volume":"374","author":"Ewer","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2018.01.010_bib1170","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1080\/21645515.2016.1238535","article-title":"Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: an open phase I\/II trial in healthy adults in Russia","volume":"13","author":"Dolzhikova","year":"2017","journal-title":"Hum Vaccines Immunotherap"},{"key":"10.1016\/j.coviro.2018.01.010_bib1175","doi-asserted-by":"crossref","first-page":"E819","DOI":"10.1503\/cmaj.170074","article-title":"Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trial","volume":"189","author":"ElSherif","year":"2017","journal-title":"CMAJ"},{"key":"10.1016\/j.coviro.2018.01.010_bib1180","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S1473-3099(17)30313-4","article-title":"Safety and immunogenicity of the rVSV\u0394G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study","volume":"17","author":"Heppner","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.coviro.2018.01.010_bib1185","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1056\/NEJMoa1614067","article-title":"Phase 2 placebo-controlled trial of two vaccines to prevent Ebola in Liberia","volume":"377","author":"Kennedy","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2018.01.010_bib1190","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0140-6736(15)61117-5","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial","volume":"386","author":"Henao-Restrepo","year":"2015","journal-title":"Lancet"}],"container-title":["Current Opinion in Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625717301153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625717301153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:01:56Z","timestamp":1761818516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879625717301153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":119,"alternative-id":["S1879625717301153"],"URL":"https:\/\/doi.org\/10.1016\/j.coviro.2018.01.010","relation":{},"ISSN":["1879-6257"],"issn-type":[{"value":"1879-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune barriers of Ebola virus infection","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coviro.2018.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}